Consumer telehealth · Peptide & specialty medication
Pepti
Pepti is a direct-to-consumer peptide and specialty medication telehealth company, with Hello Pepti as the patient-facing surface. Licensed physicians review patients online and prescriptions ship through pharmacy partners. Compounded medications are not FDA-approved finished drugs.
Strong fit
- Consumers comparing LegitScript-certified peptide telehealth with licensed physician access
- Patients who want compounding-pharmacy fulfillment across a wide U.S. footprint
- Buyers evaluating GLP-1, weight, muscle, and anti-aging style offerings through a telehealth front door
Weak fit
- Anyone treating compounded medications as if they were FDA-approved finished drugs
- Patients who need an in-person specialist relationship rather than a DTC telehealth consult
- Buyers who primarily need provider-side EHR or intake tools (wrong category)
Bottom line
Pepti earns a Recommend among direct-to-consumer telehealth options for peptide and related specialty medication programs, with the Hello Pepti app and hellopepti.com as the patient-facing surface. The platform connects licensed physicians and FDA-registered compounding pharmacies and markets LegitScript certification plus coverage across 50 states and D.C. Pepti itself is not a pharmacy or the prescribing clinician, which matters for how you read accountability. Compounded medications are not FDA-approved products, so diligence on the physician network and pharmacy partners still belongs on the checklist. Score reflects a relatively constructive compliance posture for this category, with the usual compounded-med caveats left explicit.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Pepti earns a Recommend among direct-to-consumer telehealth options for peptide and related specialty medication programs, with the Hello Pepti app and hellopepti.com as the patient-facing surface. The platform connects licensed physicians and FDA-registered compounding pharmacies and markets LegitScript certification plus coverage across 50 states and D.C. Pepti itself is not a pharmacy or the prescribing clinician, which matters for how you read accountability. Compounded medications are not FDA-approved products, so diligence on the physician network and pharmacy partners still belongs on the checklist. Score reflects a relatively constructive compliance posture for this category, with the usual compounded-med caveats left explicit.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Pepti | 7.9 | 7.6 |
| AgelessRx | 7.3 | 7.0 |
| Henry Meds | 6.7 | 6.3 |
Pricing
| Item | Detail |
|---|---|
| Model | Direct-to-consumer programs combining consult and medication fulfillment pricing. |
| What usually drives cost | Which treatment and dose; optional at-home labs; physician-approved dose increases billed at pharmacy cost. Vendor publishes all-in monthly prices with no membership fee. |
| What to ask in diligence | Total monthly cost at your target dose, pharmacy partner identity, and what is compounded versus commercially manufactured. |
| Published pricing | $99–$369 per month all-in for prescription peptide treatments (medication, physician care, and shipping; no membership fee). Semaglutide from $99/mo and tirzepatide from $159/mo at starting doses (as of Sep 2026, from vendor product pages). Confirm current quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Pepti to function | |
| A U.S. state where the physician network and pharmacy partners can serve you | Coverage claims still need a check against your address and product. |
| Comfort that compounded medications are not FDA-approved finished drugs | This category does not work if you need approved-drug certainty only. |
| Willingness to complete telehealth intake and clinician review before medication ships | There is no legitimate skip-the-clinician path. |
| A clear treatment goal (peptide, weight, or related protocol) you can discuss with the clinician | Vague cart browsing without clinical fit wastes consult cycles. |
| Payment readiness for all-in monthly program pricing (meds, care, shipping) | Model dose increases; they change pharmacy cost. |
| What will maximize your value | |
| Confirm LegitScript, physician licensing, and compounding pharmacy identity in diligence | Platform marketing is not a substitute for partner checks. |
| Use published all-in monthly prices and ask what happens at dose changes | Surprise titration billing is a common DTC pain point. |
| Track shipping time and refill reminders after first order | Ongoing cadence is where convenience value appears. |
| Keep expectations on continuity: this is DTC telehealth, not an in-person specialty relationship | Wrong expectations drive chargebacks and frustration. |
| Read what Pepti is not: it is not the pharmacy or the prescribing clinician | Accountability clarity matters when something goes wrong. |
| Deal-breakers | |
| You need FDA-approved finished drugs only and will not accept compounded options. | |
| You need an in-person specialist relationship rather than DTC telehealth. | |
| You are shopping for provider-side EHR or intake software (wrong category). | |
| You are unwilling to complete clinician review before medication is fulfilled. | |
| Your state or clinical situation is outside what the network can support. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Sign-up → clinician review | Typically 1–3 days after intake, depending on questionnaire completeness and clinician queue |
| 2 | Clinician review → medication ships | Often several days after approval, varying by pharmacy partner and product |
| 3 | First order → ongoing refill cadence | Monthly or protocol-based refills once dose and shipping rhythm stabilize (often 2–6 weeks to feel steady) |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.